Get started
Author

Laurie Ann Ford

Observed names: Laurie A Ford, Laurie A. Ford, Laurie Ford
OpenAlex ID: A5110324746
Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival
2002 · Mustafa Benekli, Zheng Xia, et al. · Blood · 180
PDF
Myelodysplastic syndromes and autoimmune diseases—Case series and review of literature
2013 · Omar Al Ustwani, Laurie A. Ford, et al. · Leukemia Research · 83
Hypoxia-inducible factor-1α protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia
2010 · George Deeb, Mary M. Vaughan, et al. · Leukemia Research · 80
Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemia
2015 · Ashkan Emadi, Rawan Faramand, et al. · American Journal of Hematology · 77
PDF
Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy
2016 · Pragya Srivastava, Benjamin E. Paluch, et al. · Oncotarget · 69
PDF
Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia
2013 · Hun Ju Lee, Josephia R. Muindi, et al. · Cancer · 67
PDF
Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease‐free survival
2004 · Attaya Suvannasankha, Hans Minderman, et al. · British Journal of Haematology · 63
PDF
Decitabine and Sorafenib Therapy in FLT-3 ITD-Mutant Acute Myeloid Leukemia
2015 · Monica R. Muppidi, Scott Portwood, et al. · Clinical Lymphoma Myeloma & Leukemia · 51
Truncated STAT proteins are prevalent at relapse of acute myeloid leukemia
2001 · Zheng Xia, Sheila N.J Sait, et al. · Leukemia Research · 51
Phase I/II Trial of Nanomolecular Liposomal Annamycin in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
2013 · Meir Wetzler, Debora A. Thomas, et al. · Clinical Lymphoma Myeloma & Leukemia · 45
Myeloid blastic transformation of myeloproliferative neoplasms—A review of 112 cases
2010 · Syed J. Noor, Wei Tan, et al. · Leukemia Research · 38
Is obesity a prognostic factor for acute myeloid leukemia outcome?
2011 · Hun Ju Lee, Andrea S. Licht, et al. · Annals of Hematology · 35
Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years old
2015 · Neha Gupta, Austin Miller, et al. · American Journal of Hematology · 32
PDF
Concordance of Pharmacogenetic Polymorphisms in Tumor and Germ Line DNA in Adult Patients with Acute Myeloid Leukemia
2007 · Joli R. Weiss, Maria R. Baer, et al. · Cancer Epidemiology Biomarkers & Prevention · 29
Smoking adversely affects survival in acute myeloid leukemia patients
2011 · Ramya Varadarajan, Andrea S. Licht, et al. · International Journal of Cancer · 27
PDF
XPD DNA Nucleotide Excision Repair (NER) Gene Polymorphisms Associated with DNA Repair Deficiency May Predict Better Treatment Outcomes in Secondary Acute Myeloid Leukemia (AML).
2009 · Nataliya Kuptsova-Clarkson, Christine Ambrosone, et al. · Blood · 25
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: Possible role of cytarabine
2008 · Cecilia Arana-Yi, AnneMarie W. Block, et al. · Leukemia Research · 20
Down-regulation of signal transducer and activator of transcription 3 improves human acute myeloid leukemia-derived dendritic cell function
2013 · Michael T. Brady, Austin Miller, et al. · Leukemia Research · 18
Routine immunophenotyping in acute leukemia: Role in lineage assignment and reassignment
2006 · Misbah Qadir, Maurice Barcos, et al. · Cytometry Part B Clinical Cytometry · 18
PDF
The 4′-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells
2006 · Tracy A. Brooks, Kieran L. O’Loughlin, et al. · Investigational New Drugs · 17
Phase 1 study of arsenic trioxide, high‐dose cytarabine, and idarubicin to down‐regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemia
2011 · Meir Wetzler, Chris Andrews, et al. · Cancer · 16
PDF
Long-term safety and efficacy of cyclosporin A therapy for T-cell large granular lymphocyte leukemia
2009 · Attaphol Pawarode, Paul K. Wallace, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 15
Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapse
2010 · Eunice S. Wang, Sheila N.J. Sait, et al. · Cancer Genetics and Cytogenetics · 14
XPD DNA nucleotide excision repair gene polymorphisms associated with DNA repair deficiency predict better treatment outcomes in secondary acute myeloid leukemia.
2010 · Nataliya Kuptsova-Clarkson, Christine B Ambrosone, et al. · PubMed · 14
A phase I study of intermediate dose cytarabine in combination with lenalidomide in relapsed/refractory acute myeloid leukemia
2016 · Elizabeth A. Griffiths, William E. Brady, et al. · Leukemia Research · 10
Works count: 62
Citation count: 1,145
H-index: 18
I10-index: 25
Year
Topic
Type